1. Dual human epidermal growth factor receptor 2 blockade for the treatment of HER2-positive breast cancer

   • Ricardo H. Alvarez
   • Gabriel N. Hortobagyi

   Conference Paper 03 February 2013 Pages: 103 - 110

   

2. Effects of toremifene versus tamoxifen on breast cancer patients: a meta-analysis

   • Feng Chi
   • Rong Wu
   • Zhaoguo Xu

   Review Article 25 December 2012 Pages: 111 - 122

   

3. The current status of positron emission mammography in breast cancer diagnosis

   • Vasileios Kalles
   • George C. Zografos
   • Antonia Gounaris

   Review Article 13 December 2012 Pages: 123 - 130

   

4. Phase II study of bi-weekly irinotecan for patients with previously treated HER2-negative metastatic breast cancer: KMBOG0610B

   • Hidetoshi Hayashi
   • Junji Tsurutani
   • Kazuhiko Nakagawa

   Original Article 29 November 2011 Pages: 131 - 136

   

5. Diffusion-weighted imaging (b value = 1500 s/mm²) is useful to decrease false-positive breast cancer cases due to fibrocystic changes

   • Miho Ochi
   • Toshiro Kuroiwa
   • Masamitsu Hatakenaka

   Original Article 10 December 2011 Pages: 137 - 144

   

6. Prognostic factors for stage IV hormone receptor-positive primary metastatic breast cancer

   • Akiko Kawano
   • Chikako Shimizu
   • Yasuhiro Fujiwara

   Original Article 03 December 2011 Pages: 145 - 151

   

7. Power Doppler breast ultrasound: association of vascularization and ER/c-erbB-2 co-expression in invasive breast carcinoma

   • Shou-Tung Chen
   • Shou-Jen Kuo
   • Dar-Ren Chen

   Original Article 29 November 2011 Pages: 152 - 158

   

8. Establishment of a standardized gene-expression analysis system using formalin-fixed, paraffin-embedded, breast cancer specimens

   • Mutsuko Ibusuki
   • Peifen Fu
   • Hirotaka Iwase

   Original Article 03 December 2011 Pages: 159 - 166

   

9. Predictive value of FDG PET/CT for pathologic axillary node involvement after neoadjuvant chemotherapy

   • Bhumsuk Keam
   • Seock-Ah Im
   • Yung-Jue Bang

   Original Article 07 February 2012 Pages: 167 - 173

   

10. Serum leptin level and waist-to-hip ratio (WHR) predict the overall survival of metastatic breast cancer (MBC) patients treated with aromatase inhibitors (AIs)

    • Mehmet Artac
    • Hakan Bozcuk
    • Mustafa Ozdogan

    Original Article 28 December 2011 Pages: 174 - 180

    

11. Clinical application of the one-step nucleic acid amplification method to detect sentinel lymph node metastasis in breast cancer

    • Yasuaki Sagara
    • Yasuyo Ohi
    • Yoshiatsu Sagara

    Original Article 28 December 2011 Pages: 181 - 186

    

12. A case of tumor-forming pseudoangiomatous stromal hyperplasia of the breast

    • Hiroyuki Takagi
    • Junichi Miyairi
    • Shinichi Tsuchiya

    Case Report 14 January 2010 Pages: 187 - 190

    

13. Early distant relapse in early stage triple-negative breast cancer: usefulness of FDG-PET for diagnosis of distant metastases

    • Yukihiro Hama
    • Keiichi Nakagawa

    Case Report 16 January 2010 Pages: 191 - 193